Local and systemic radiation for palliation of metastatic disease

Urologic Clinics of North America

Volumn 26, Issue 2, 1999, Pages 391-402

  Friedland, J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ESTRAMUSTINE; ETIDRONIC ACID RE 186; FLUOROURACIL; GONADORELIN DERIVATIVE; GOSERELIN; IODINE 131; LEXIDRONAM SAMARIUM SM 153; MITOMYCIN C; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHORUS 32; RHENIUM 186; SAMARIUM 153; STRONTIUM 89; STRONTIUM CHLORIDE; TIN; VINBLASTINE;

ANALGESIA; BONE MARROW SUPPRESSION; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NERVE BLOCK; PRIORITY JOURNAL; PROSTATE CANCER; RADIOISOTOPE THERAPY; REVIEW;

EID: 0032912715     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70078-1     Document Type: Article

References (57)

1. H.L. Atkins L.F. Mausher S.C. Srivastava Biodistribution of Sn-117m (4+) DTPA for palliative therapy of painful osseous metastases Radiology 186 1993 279 283
2. Ben-Josef E, Filipzack L, Davis L, et al: Repeated administration of strontium-89 for palliation of painful osseous metastases [abstract 204]. Presented at the American Society of Clinical Oncology Conference, Denver, May 1997.
3. E. Ben-Josef D.R. Lucas S. Vasan Selective accumulation of strontium-89 in metastatic bone deposits: Radio-histological correlation Nucl Med Commun 16 1995 457 463
4. P. Blitzer Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis Cancer 55 1985 1468 1472
5. J.J. Bolger D.P. Dearnaley D. Kirk Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: Preliminary report of a multicenter trial Semin Oncol 20 3 suppl 1993 32 33
6. K. Buchali H.J. Correns D. Schnorr Hofer R. Bergmann H. Radioaktive Isotope in Klinik und Forschung: 16.Band 1984 Egermann Vienna
7. P.G. Bullough Atlas of Orthopedic Pathology with Clinical and Radiologic Correlation's ed 2 1992 Gower Medical Publishing New York 6 17–29
8. D. Cole A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastasis Clin Oncol 1 1989 59 62
9. E.D. Crawford M.A. Eisenberger D.G. McLeod A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419 424
10. Dahut W, Arcenas A, Feldman S, et al: Strontium-89 (Sr-89 Metastron) and estramustine (EM) in hormone refractory prostate cancer (HRPC): A phase II study [abstract 1182]. Presented at the American Society of Clinical Oncology Conference, Denver, May 1997.
11. De Klerk J.M. B.A. Zonnenberg van het Schip A.D. Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer Eur J Nucl Med 21 1994 1114 1120
12. S.D. Fossa E. Paus M. Lochoff Strontium-89 in metastasis from hormone resistant prostate cancer: Palliation effect and biochemical changes Br J Cancer 66 1992 177 180
13. 89Sr therapy in 200 patients with skeletal metastases from prostatic carcinoma Nuklearmedizin 31 1992 48 52
14. P. Hoskin P. Price D. Easton A prospective randomized trial of 4Gy or 8Gy single doses in the treatment of metastatic bone pain Radiother Oncol 23 1992 74 78
15. Y. Kimura K. Hamamoto M. Furudate Effectiveness of the radioactive strontium (89Sr) chloride agent, SMS.2P, for pain palliation in patients with metastatic bone tumor in phase III multicenter clinical trial Kaku Igaku 33 1996 1347 1358
16. G.T. Krishnamurthy F.M. Swailem S.C. Srivastava Tia-117m (4+) DTPA: Pharmacokinetics and imaging characteristics in patients with metastatic bone pain J Nucl Med 38 1997 230 237
17. D. Kuban T. Delbridge A.M. El-Mahdi Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate J Urol 141 1989 572 574
18. J. Kutzner W. Grimm K. Hahn Interne Strahlentherapie mit strontium-89 bei metastasenbedingten Schmerzzustanden Munch Med Wschr 119 1977 1251 1252
19. A.H. Laing D.M. Ackery R.J. Bayly Strontium-89 chloride for pain palliation in prostatic skeletal malignancy Br J Radiol 64 1991 816 822
20. C.K. Lee D.M. Aeppli J. Unger Strontium-89 (Metastron) for palliative treatment of bony metastases: The University of Minnesota experience Am J Clin Oncol 19 1996 102 107
21. V.J. Lewington A.J. McEwan D.M. Ackery A prospective randomized double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone Eur J Cancer 27 1991 954 958
22. L. Madsen Painful bone metastasis: Efficacy of radiotherapy assessed by the patients. A randomized trial comparing 4Gy × 6 versus 10Gy × 2 Int J Radiat Oncol Biol Phys 9 1983 1775 1779
23. I. Malmberg U. Persson A. Ask Painful bone metastasis in hormone refractory prostate cancer: Economic costs of strontium-89 and/or external radiotherapy Urology 50 1997 747 753
24. J.R. Maxfield J.G. Maxfield W.S. Maxfield The use of radioactive phosphorous and testosterone in metastatic bone lesions from breast and prostate South Med J 51 1958 320 328
25. H.D. Maxon L.E. Schroder V.S. Hertzberg Rhenium-186 (Sn) HEDP for treatment of painful osseous metastases: Results of a double-blind crossover comparison with placebo J Nucl Med 32 1991 1877 1881
26. A.J. McEwan A.T. Porter P.M. Venner An evaluation of the safety and efficacy of treatment with strontium-89 in patients who have previously received wide field radiotherapy Antibody Immunoconjugates Radiopharmaceuticals 3 1990 91 98
27. 89Sr-chloride) in patients with prostate cancer metastatic to bone Nucl Med Commun 15 1994 499 504
28. W.C. Mertens A.T. Porter R.H. Reid Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report J Nucl Med 33 1992 1437 1443
29. 89Sr compared to external beam and hemibody irradiation: A historical perspective Cancer Invest 7 1989 139 160
30. T. Okawa M. Kita M. Goto Randomized prospective clinical study of small, larger and twice-a-day fraction radiotherapy for painful bone metastases Radiother Oncol 13 1988 99 104
31. F.J. Papatheofanis Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma J Nucl Med 38 1997 1175 1179
32. 89Sr and external beam radiotherapy of prostatic bony metastases Br J Radiol 70 1997 594 598
33. C. Pecher Biological investigations with radioactive calcium and strontium: Preliminary report on the use of radioactive strontium in the treatment of metastatic bone cancer Univ Calif Publ Pharmacol 2 1942 117 149
34. F. Pons R. Herranz A. Garcia Strontium-89 for palliation of pain from bone metastasis in patients with prostate and breast cancer Eur J Nucl Med 24 1997 1210 1214
35. A.T. Porter A.J.B. McEwan Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: Results of a randomized controlled trial Semin Oncol 20 3 suppl 1993 38 43
36. Porter AT, Crispen RG, Sadasivan R, et al: Tumoricidal effect of strontium-89 in prostate cancer based on PSA and pain delay [abstract 1214]. Presented at the American Society of Clinical Oncology Conference, Denver, May 1997.
37. A.T. Porter A.J.B. McEwan J.E. Powe Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int J Radiat Oncol Biol Phys 25 1993 805 813
38. A.T. Porter The use of strontium-89 in metastatic cancer: US and UK experience Oncology 8 suppl 1994 24 29
39. C. Poulter D. Cosmatos P. Rubin A report of RTOG 8206: A phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases Int J Radiat Oncol Biol Phys 23 1992 207 214
40. P. Price P.J. Hoskin D. Easton Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases Radiother Oncol 65 1986 247 255
41. P.M. Quilty D. Kirk J.J. Bolger A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer Radiother Oncol 31 1994 33 40
42. R. Robinson G.M. Blake D.F. Preston Strontium-89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone Radiographics 9 1989 271 281
43. R. Robinson D.F. Preston M. Schiefelbein Strontium-89 therapy for the palliation of pain due to osseous metastases JAMA 274 1995 420 424
44. R. Robinson J.A. Spicer D.F. Preston Treatment of metastatic bone pain with strontium-89 Nucl Med Biol 14 1987 219 222
45. R.G. Robinson D.F. Preston K.G. Baxter Clinical experience with strontium-89 in prostatic and breast cancer patients Semin Oncol 20 3 suppl 1993 44 48
46. R.G. Robinson Strontium-89: Precursor targeted therapy for pain relief of blastic metastatic disease Cancer 72 1993 3433 3435
47. C.L. Rogers B.L. Speiser P.C. Ram Efficacy and toxicity of intravenous strontium-89 for symptomatic osseous metastases J Brachytherapy International 14 1998 133 142
48. O. Salazar P. Rubin F.R. Hendrickson Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors: Final radiation therapy oncology group report Cancer 58 1986 29 36
49. C.G. Schmidt N. Firusian 89-Sr for the treatment of incurable pain in patients with neoplastic osseous infiltrations Int J Clin Pharmacol Ther Toxicol 9 1974 199 205
50. R. Sciuto C.L. Maini A. Tofani Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89 Nucl Med Commun 17 1996 799 804
51. E.B. Silberstein A.H. Elgazazar A. Kapilivsky Phosphorous-32 radiopharmaceuticals for the treatment of painful osseous metastases Semin Nucl Med 21 1992 17 27
52. M.S. Soloway G. Chodak N.J. Vogelzang Zoladex versus orchiectomy in treatment of advanced prostate cancer: A randomized trial Urology 37 1991 46 51
53. D. Tong L. Gillick F. Hendrickson The palliation of symptomatic osseous metastases: Final results of the study by the radiation therapy oncology group Cancer 50 1982 893 899
54. S.M. Tu E.S. Delpassand D. Jones Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer Urol Oncol 2 1997 191 197
55. J.H. Turner P.G. Claringbold A.A. Martindale Samarium-153 EDTMP and radiosensitizing chemotherapy for treatment of disseminated skeletal metastases [abstract] Eur J Nucl Med 16 1992 S125
56. Wehbe T, Akerley W, Stein B, et al: Strontium-89, estramustine and vinblastine (SEV) in hormone refractory prostate carcinoma (HRPC): Concurrent chemoradiotherapy [abstract 1110]. Presented at the American Society of Clinical Oncology Conference, Denver, May 1997.
57. Zelefsky MJ, Scher HI, Forman JD, et al: Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: A comparison of single dose and fractionated regimens. Int J Rad